HR Execs on the Move

Sanofi Genzyme

www.sanofigenzyme.com

 
Sanofi Genzyme, the specialty care business unit of Sanofi, focuses on rare diseases, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Richard Manning
Vice President/Head Patient Support Services Dupixent Profile
Tejdip Singh
Senior Medical Director Clinical Research and Development Profile
William Bonville
Principal Auditor R&D Site Quality Operations Gene and Cell Therapy Genomics Medicine Profile
Greg Hurlbut
R&D Director/ Associate Director / Sr. Principal Scientist Profile
Scott Eisenbeis
VP R&D Strategy Profile

Similar Companies

CLS Health

CLS Health is a multi-specialty medical group with 90+ providers providing comprehensive inpatient & outpatient care in Houston, TX

BrainsWay

BrainsWay is an Israeli company with international operations that is engaged in the development of a medical device that uses H-coil for deep transcranial magnetic stimulation as a noninvasive treatment for depression.

NEW Health Programs Association

NEW Health provides high quality health care services for all residents within the communities we serve. We offer a sliding fee discount for health services to those who qualify.   We believe that all people deserve...

Jamieson Wellness

Jamieson Wellness is a Canadian company that manufactures, distributes, and markets high quality natural health products. Their portfolio includes the Jamieson brand, which is Canadas #1 consumer health brand, as well as the youtheory, Progressive, Sm...

Sagimet

Sagimet Biosciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics to treat important diseases such as the liver disease NASH and specific cancers, with focus on targeting dysfunctional metabolic pathways. The company has unique expertise in FASN biology and has created a platform of proprietary FASN inhibitors.